Processed pseudogenes acquired somatically during cancer development.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsCooke, Susanna L
Pipinikas, Christodoulos P
Tubio, Jose M C
Bignell, Graham R
Tarpey, Patrick S
Teixeira, Vitor H
Dodoran, Maryam S
Teague, Jon W
Butler, Adam P
Grundy, Richard G
Flanagan, Adrienne M
Reis-Filho, Jorge S
Taylor, Jack A
Hayes, Neil D
Janes, Sam M
Futreal, P Andrew
Stratton, Michael R
Campbell, Peter J
MetadataShow full item record
CitationNat Commun. 2014, 5:3644
AbstractCancer evolves by mutation, with somatic reactivation of retrotransposons being one such mutational process. Germline retrotransposition can cause processed pseudogenes, but whether this occurs somatically has not been evaluated. Here we screen sequencing data from 660 cancer samples for somatically acquired pseudogenes. We find 42 events in 17 samples, especially non-small cell lung cancer (5/27) and colorectal cancer (2/11). Genomic features mirror those of germline LINE element retrotranspositions, with frequent target-site duplications (67%), consensus TTTTAA sites at insertion points, inverted rearrangements (21%), 5' truncation (74%) and polyA tails (88%). Transcriptional consequences include expression of pseudogenes from UTRs or introns of target genes. In addition, a somatic pseudogene that integrated into the promoter and first exon of the tumour suppressor gene, MGA, abrogated expression from that allele. Thus, formation of processed pseudogenes represents a new class of mutation occurring during cancer development, with potentially diverse functional consequences depending on genomic context.
DescriptionTo access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files. This article is open access.
- Pseudogene in cancer: real functions and promising signature.
- Authors: Xiao-Jie L, Ai-Mei G, Li-Juan J, Jiang X
- Issue date: 2015 Jan
- Pseudogene-expressed RNAs: a new frontier in cancers.
- Authors: Shi X, Nie F, Wang Z, Sun M
- Issue date: 2016 Feb
- Processed pseudogene insertions in somatic cells.
- Authors: Kazazian HH Jr
- Issue date: 2014
- Pseudogenes transcribed in breast invasive carcinoma show subtype-specific expression and ceRNA potential.
- Authors: Welch JD, Baran-Gale J, Perou CM, Sethupathy P, Prins JF
- Issue date: 2015 Feb 22
- Oct4 pseudogenes are transcribed in cancers.
- Authors: Suo G, Han J, Wang X, Zhang J, Zhao Y, Zhao Y, Dai J
- Issue date: 2005 Dec 2